Feel Comfortable Switching Many Patients to Clopidogrel Early After a Stent
You'll face questions about whether it's okay for patients to switch antiplatelet meds after a coronary stent.
Current guidelines prefer dual antiplatelet therapy with aspirin plus Brilinta (ticagrelor) or Effient (prasugrel) after an acute coronary syndrome...instead of aspirin plus clopidogrel.
Earlier studies suggest that Brilinta or Effient reduces the risk of a recurrent CV event more than clopidogrel...but causes more bleeding.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote